Akari Therapeutics Plc (AKTX)
7.52
-0.33
(-4.20%)
USD |
NASDAQ |
Aug 24, 16:00
7.52
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Total Liabilities (Quarterly) : 20.03M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.03M |
| March 31, 2026 | 19.51M |
| December 31, 2025 | 19.67M |
| September 30, 2025 | 22.69M |
| June 30, 2025 | 25.31M |
| March 31, 2025 | 29.21M |
| December 31, 2024 | 28.43M |
| September 30, 2024 | 9.428M |
| June 30, 2024 | 8.779M |
| March 31, 2024 | 6.325M |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | 3.045M |
| March 31, 2022 | 5.524M |
| December 31, 2021 | 6.093M |
| September 30, 2021 | 3.356M |
| June 30, 2021 | 3.242M |
| March 31, 2021 | 3.903M |
| December 31, 2020 | 5.220M |
| September 30, 2020 | 8.835M |
| June 30, 2020 | 11.11M |
| Date | Value |
|---|---|
| March 31, 2020 | 8.153M |
| December 31, 2019 | 8.574M |
| September 30, 2019 | 7.419M |
| June 30, 2019 | 6.523M |
| March 31, 2019 | 7.590M |
| December 31, 2018 | 4.918M |
| September 30, 2018 | 6.324M |
| June 30, 2018 | 8.493M |
| March 31, 2018 | 9.171M |
| December 31, 2017 | 11.90M |
| September 30, 2017 | 9.385M |
| June 30, 2017 | 9.201M |
| March 31, 2017 | 14.12M |
| December 31, 2016 | 11.90M |
| September 30, 2016 | 11.03M |
| June 30, 2016 | 17.05M |
| March 31, 2016 | 16.60M |
| December 31, 2015 | 21.17M |
| September 30, 2015 | 37.84M |
| June 30, 2015 | 1.987M |
| March 31, 2015 | 1.722M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 62.80M |
| Cellectis SA | 226.30M |
| argenx SE | -- |
| Autolus Therapeutics Plc | 418.39M |
| Evaxion AS | 9.849M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 38.62M |
| Shareholders Equity (Quarterly) | 18.60M |
| Debt to Equity Ratio | 0.0373 |
| Current Ratio | 0.5973 |
| Net Debt Paydown Yield | 1.29% |